Diversity, equity, and inclusion have become a focal point since the COVID-19 pandemic exposed the disproportionate —and systemically ingrained— health disparities certain populations suffer from in the United States. IRBs have the difficult responsibility of both protecting participants from harm and ensuring the inclusion of underrepresented participants in research. Read more
TAG ARCHIVES FOR clinical research
The clinical trial workforce's incredible response to the COVID-19 pandemic has generated some of the most positive media coverage and public acclaim the drug and device research and development industry has ever seen. "We need to harness that public awareness," says Elisa Hurley, PhD, executive director of PRIM&R. Read more
Do the high hopes of many that a “silver bullet” treatment for COVID-19 is forthcoming any day now represent a red herring to the public where the complexities of clinical research are concerned? Read more
If you have ever reviewed a research study as a member or administrator of an IRB that included or involved pregnant research participants, you may be eligible for a new study on the enrollment of pregnant women in clinical research. As a practicing obstetrician-gynecologist, bioethicist, and the study principal investigator, I hope you will consider participating in a 20 to 25 minute online survey on IRB views and experiences reviewing research involving pregnant women. Read more
PRIM&R is pleased to welcome Boghuma Kabisen Titanji, MD, MSc, PhD, as one of the keynote speakers at the upcoming 2015 Advancing Ethical Research Conference to be hosted in Boston November 12-15, 2015. Dr. Titanji will lead off the conference program on November 13 with an address titled, Facts and Fiction: The Ethics of Healthcare Research in Developing Countries.
PRIM&R: How did you develop an interest in your field?
Boghuma Kabisen Titanji (BT): Very early on during my training as a physician in my home country Cameroon, I [...] Read more